Overall, 46% of the respondents correctly identified chronic cough. Of these, allergists/immunologists had the highest ...
Female sex is associated with up to 44% increased odds of chronic rhinosinusitis without nasal polyps (CRSsNP), but 37% ...
The company which supplies the electronic patient record system used by the majority of GPs in Britain is being circled by a ...
FDA approves cancer drug belantamab mafodotin-blmf for relapsed multiple myeloma in combination with bortezomib and dexamethasone.
13hon MSN
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Optum’s UK operation is reportedly is being circled by a pack of potential buyers, just two years after it last changed hands.
Patients with vs without diabetes demonstrated a higher risk for uUTI treatment failure, although the observed difference was unlikely to be clinically relevant.
GSK's London-listed shares fell nearly 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...
UK retail sales rose 0.5% in September, beating expectations. Online sales climbed for eighth consecutive month as consumer ...
Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.
GlobalData on MSN
GSK’s Blenrep gains FDA approval for myeloma treatment
The approval is based on data from a Phase III trial evaluating patients who had received two or more previous treatments.
The Food and Drug Administration’s approval of the cancer drug Blenrep late Thursday offered some vindication for GSK, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results